A Study of LIQ861 (Inhaled Treprostinil) in Adults With Systemic Sclerosis Who Have Symptomatic Raynaud's Phenomenon Attacks
Clinical trial NCT07748000 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07748000
- Sponsor
- Liquidia Technologies, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-26
- Primary completion
- 2027-02-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.